These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28587059)

  • 1. Selected Risk Nutritional Factors for Chemotherapy-Induced Polyneuropathy.
    Grim J; Ticha A; Hyspler R; Valis M; Zadak Z
    Nutrients; 2017 May; 9(6):. PubMed ID: 28587059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of vitamin E on chemotherapy-induced peripheral neuropathy: a meta-analysis of randomized controlled trials.
    Eum S; Choi HD; Chang MJ; Choi HC; Ko YJ; Ahn JS; Shin WG; Lee JY
    Int J Vitam Nutr Res; 2013; 83(2):101-11. PubMed ID: 24491883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review.
    Schloss JM; Colosimo M; Airey C; Masci PP; Linnane AW; Vitetta L
    Clin Nutr; 2013 Dec; 32(6):888-93. PubMed ID: 23647723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum micronutrients and prealbumin during development and recovery of chemotherapy-induced peripheral neuropathy.
    Velasco R; Santos C; Soler G; Gil-Gil M; Pernas S; Galan M; Palmero R; Bruna J
    J Peripher Nerv Syst; 2016 Sep; 21(3):134-41. PubMed ID: 27282616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Narrative Review of Complementary Nutritional Supplements for Chemotherapy-induced Peripheral Neuropathy.
    Liu YW; Liu CT; Su YL; Tsai MY
    Altern Ther Health Med; 2020 Jul; 26(4):43-49. PubMed ID: 31634876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221.
    Chen CS; Zirpoli G; Barlow WE; Budd GT; McKiver B; Pusztai L; Hortobagyi GN; Albain KS; Damaj MI; Godwin AK; Thompson A; Henry NL; Ambrosone CB; Stringer KA; Hertz DL
    J Natl Compr Canc Netw; 2023 Nov; 21(11):1172-1180.e3. PubMed ID: 37935109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced polyneuropathy: major agents and assessment by questionnaires.
    Zedan AH; Vilholm OJ
    Basic Clin Pharmacol Toxicol; 2014 Aug; 115(2):193-200. PubMed ID: 24796774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy.
    Huehnchen P; Schinke C; Bangemann N; Dordevic AD; Kern J; Maierhof SK; Hew L; Nolte L; Körtvelyessy P; Göpfert JC; Ruprecht K; Somps CJ; Blohmer JU; Sehouli J; Endres M; Boehmerle W
    JCI Insight; 2022 Mar; 7(6):. PubMed ID: 35133982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxaliplatin- and docetaxel-induced polyneuropathy: clinical and neurophysiological characteristics.
    Bennedsgaard K; Ventzel L; Andersen NT; Themistocleous AC; Bennett DL; Jensen TS; Tankisi H; Finnerup NB
    J Peripher Nerv Syst; 2020 Dec; 25(4):377-387. PubMed ID: 32902058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of high tone therapy and transcutaneous electrical nerve stimulation therapy in chemotherapy-induced polyneuropathy.
    Schaffler-Schaden D; Sassmann R; Johansson T; Gampenrieder SP; Rinnerthaler G; Lampl K; Herfert J; Lenzhofer C; Landkammer YT; Rieder F; Greil R; Flamm M; Niebauer J
    Medicine (Baltimore); 2020 May; 99(19):e20149. PubMed ID: 32384502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and electromyography characteristics of chemotherapy-induced polyneuropathy].
    Kholodova NB; Ponkratova YA; Sinkin MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):59-66. PubMed ID: 29053122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical characteristics and treatment of polyneuropathy developed after chemotherapy].
    Kholodova NB; Sotnikov VM; Dobrovol'skaia NIu; Ponkratova IuA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5):20-4. PubMed ID: 23739498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Review of Nutritional Lab Correlates with Chemotherapy Induced Peripheral Neuropathy.
    Tofthagen C; Tanay M; Perlman A; Starr J; Advani P; Sheffield K; Brigham T
    J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35054049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of chemotherapy-induced peripheral neuropathy on treatment delivery in nonmetastatic breast cancer.
    Speck RM; Sammel MD; Farrar JT; Hennessy S; Mao JJ; Stineman MG; DeMichele A
    J Oncol Pract; 2013 Sep; 9(5):e234-40. PubMed ID: 23943894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical identification of predictors for peripheral neuropathy associated with administration of bortezomib, taxanes, oxaliplatin or vincristine using ordered logistic regression analysis.
    Kanbayashi Y; Hosokawa T; Okamoto K; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Taniwaki M
    Anticancer Drugs; 2010 Oct; 21(9):877-81. PubMed ID: 20679888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothermia for preventing chemotherapy-induced neuropathy - a pilot study on safety and tolerability in healthy controls.
    Bandla A; Sundar R; Liao LD; Sze Hui Tan S; Lee SC; Thakor NV; Wilder-Smith EP
    Acta Oncol; 2016; 55(4):430-6. PubMed ID: 26360921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy-induced peripheral neuropathy].
    Noguchi E; Maeda Y
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1773-6. PubMed ID: 22083183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral neuropathy in colorectal cancer survivors: the influence of oxaliplatin administration. Results from the population-based PROFILES registry.
    Beijers AJ; Mols F; Tjan-Heijnen VC; Faber CG; van de Poll-Franse LV; Vreugdenhil G
    Acta Oncol; 2015 Apr; 54(4):463-9. PubMed ID: 25417732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy-induced peripheral neuropathy: an unresolved issue].
    Velasco R; Bruna J
    Neurologia; 2010 Mar; 25(2):116-31. PubMed ID: 20487712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and psychometric evaluation of the chemotherapy-induced peripheral neuropathy assessment tool.
    Tofthagen CS; McMillan SC; Kip KE
    Cancer Nurs; 2011; 34(4):E10-20. PubMed ID: 21242773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.